Research Article
Correlation between Skip N2 Metastases and SUVmax, Long Diameter of Tumor, and Ki67 Expression in Patients with Non-Small-Cell Lung Cancer
Table 2
Clinical symptoms of patients in SN2 and non-SN2 groups.
| Variables | SN2 group () | Non-SN2 group () | | value |
| Age | | | 0.485 | 0.629 | Gender | | | — | 0.14 | Male | 16 | 29 | | | Female | 3 | 17 | | | Smoking | | | — | 0.803 | Yes | 4 | 11 | | | No | 15 | 35 | | | Tumor site | | | — | 0.658 | Right upper lobe | 6 | 12 | | | Middle lobe | 2 | 5 | | | Right low lobe | 3 | 12 | | | Left upper lobe | 4 | 7 | | | Left low lobe | 4 | 10 | | | Pleural invasion | | | — | 0.875 | Yes | 3 | 8 | | | No | 16 | 38 | | | Pathological type | | | 1.785 | 0.182 | Squamous carcinoma | 10 | 16 | | | Nonsquamous carcinoma | 9 | 30 | | | Ki67 expression | | | 2.828 | 0.008 | Long diameter of tumor (mm) | | | 1.765 | 0.123 | Tumor SUVmax | | | 0.823 | 0.396 |
|
|
SUVmax: maximum standardized uptake value. Fisher’s exact method.
|